10-K Filing

ACACIA RESEARCH CORP CIK: 934549 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0000934549-23-000031`
Period End Date	20221231
Filing Date	20230317
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	actg-20221231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 104 Income Statement 58 Cash Flow Statement 99 Stockholders Equity 21

Balance Sheet 104 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$287.79M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$308.94M	USD	Point-in-time
Equity securities	`EquitySecuritiesFvNi`	$361.78M	USD	Point-in-time
Equity securities	`EquitySecuritiesFvNi`	$61.61M	USD	Point-in-time
Equity securities without readily determinable fair value	`TradingSecuritiesDebt`	$5.82M	USD	Point-in-time
Equity securities without readily determinable fair value	`TradingSecuritiesDebt`	$5.82M	USD	Point-in-time
Equity method investments	`EquityMethodInvestmentsCurrent`	$30.93M	USD	Point-in-time
Equity method investments	`EquityMethodInvestmentsCurrent`	$30.93M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$8.23M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$9.52M	USD	Point-in-time
Inventories	`InventoryNet`	$14.22M	USD	Point-in-time
Inventories	`InventoryNet`	$8.93M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.76M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$19.39M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$730.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$427.99M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndInvestmentsNoncurrent`	$418.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndInvestmentsNoncurrent`	-	USD	Point-in-time
Preferred stock, par or stated value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$3.54M	USD	Point-in-time
Preferred stock, par or stated value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$4.18M	USD	Point-in-time
Goodwill	`Goodwill`	$7.47M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	$7.54M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$36.66M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$48.79M	USD	Point-in-time
Leased right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.00M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Leased right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.03M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common stock, par or stated value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$5.28M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$5.20M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total assets	`Assets`	$482.93M	USD	Point-in-time
Total assets	`Assets`	$798.86M	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	48.81M	shares	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	43.48M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	43.48M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	48.81M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.04M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.44M	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	5.39M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	16.18M	shares	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$14.06M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$6.23M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$4.74M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$3.70M	USD	Point-in-time
Royalties and contingent legal fees payable	`RoyaltiesAndContingentLegalFeesPayable`	$2.46M	USD	Point-in-time
Royalties and contingent legal fees payable	`RoyaltiesAndContingentLegalFeesPayable`	$699.00K	USD	Point-in-time
Accrued patent costs	`AccruedPatentInvestmentCostsCurrent`	$9.00M	USD	Point-in-time
Accrued patent costs	`AccruedPatentInvestmentCostsCurrent`	-	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.23M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.11M	USD	Point-in-time
Senior secured notes payable	`SecuredDebtCurrent`	$181.25M	USD	Point-in-time
Senior secured notes payable	`SecuredDebtCurrent`	$60.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$200.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$87.21M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$568.00K	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$581.00K	USD	Point-in-time
Series A warrant liabilities	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Series A warrant liabilities	`DerivativeLiabilitiesNoncurrent`	$11.29M	USD	Point-in-time
Series A embedded derivative liabilities	`EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability`	$16.84M	USD	Point-in-time
Series A embedded derivative liabilities	`EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability`	$18.45M	USD	Point-in-time
Series B warrant liabilities	`EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1`	$84.78M	USD	Point-in-time
Series B warrant liabilities	`EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1`	$96.38M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.03M	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.87M	USD	Point-in-time
Deferred income tax liabilities, net	`DeferredIncomeTaxLiabilitiesNet`	$742.00K	USD	Point-in-time
Deferred income tax liabilities, net	`DeferredIncomeTaxLiabilitiesNet`	$18.55M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.16M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.68M	USD	Point-in-time
Total liabilities	`Liabilities`	$193.68M	USD	Point-in-time
Total liabilities	`Liabilities`	$353.63M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of December 31, 2022 and 2021; aggregate liquidation preference of $35,000 as of December 31, 2022 and 2021	`PreferredStockRedemptionAmount`	$14.75M	USD	Point-in-time
Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of December 31, 2022 and 2021; aggregate liquidation preference of $35,000 as of December 31, 2022 and 2021	`PreferredStockRedemptionAmount`	$19.92M	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 300,000,000 shares authorized; 43,484,867 and 48,807,748 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common stock, par value $0.001 per share; 300,000,000 shares authorized; 43,484,867 and 48,807,748 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`CommonStockValue`	$43.00K	USD	Point-in-time
Treasury stock, at cost, 16,183,703 and 5,388,469 shares as of December 31, 2022 and 2021, respectively	`TreasuryStockValue`	$47.28M	USD	Point-in-time
Treasury stock, at cost, 16,183,703 and 5,388,469 shares as of December 31, 2022 and 2021, respectively	`TreasuryStockValue`	$98.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$648.39M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$663.28M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-181.72M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-306.79M	USD	Point-in-time
Total Acacia Research Corporation stockholders' equity	`StockholdersEquity`	$258.28M	USD	Point-in-time
Total Acacia Research Corporation stockholders' equity	`StockholdersEquity`	$419.43M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$11.04M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$11.04M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$430.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$269.32M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$288.32M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock, and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$798.86M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock, and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$482.93M	USD	Point-in-time

Income Statement 58 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$88.05M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$59.22M	USD	Annual
Cost of revenues - intellectual property operations	`CostOfRevenue`	$36.10M	USD	Annual
Cost of revenues - intellectual property operations	`CostOfRevenue`	$37.39M	USD	Annual
Engineering and development expenses - industrial operations	`ResearchAndDevelopmentExpense`	$200.00K	USD	Annual
Engineering and development expenses - industrial operations	`ResearchAndDevelopmentExpense`	$626.00K	USD	Annual
Sales and marketing expenses - industrial operations	`SellingAndMarketingExpense`	$1.54M	USD	Annual
Sales and marketing expenses - industrial operations	`SellingAndMarketingExpense`	$8.62M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$35.67M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$52.68M	USD	Annual
Total costs and expenses	`CostsAndExpenses`	$73.50M	USD	Annual
Total costs and expenses	`CostsAndExpenses`	$99.31M	USD	Annual
Operating (loss) income	`OperatingIncomeLoss`	$14.54M	USD	Annual
Operating (loss) income	`OperatingIncomeLoss`	$-40.09M	USD	Annual
Change in fair value of equity securities	`DebtSecuritiesTradingUnrealizedGainLoss`	$-263.69M	USD	Annual
Change in fair value of equity securities	`DebtSecuritiesTradingUnrealizedGainLoss`	$87.53M	USD	Annual
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	$116.13M	USD	Annual
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	$125.32M	USD	Annual
Earnings on equity investment in joint venture	`EarningsOnEquityInvestmentInJointVenture`	$3.53M	USD	Annual
Earnings on equity investment in joint venture	`EarningsOnEquityInvestmentInJointVenture`	$42.53M	USD	Annual
Net realized and unrealized (loss) gain	`DebtAndEquitySecuritiesGainLoss`	$207.19M	USD	Annual
Net realized and unrealized (loss) gain	`DebtAndEquitySecuritiesGainLoss`	$-95.85M	USD	Annual
Change in fair value of investment	`UnrealizedGainLossOnInvestments`	$-2.75M	USD	Annual
Change in fair value of investment	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Gain on sale of investment	`GainLossOnSaleOfInvestments`	-	USD	Annual
Gain on sale of investment	`GainLossOnSaleOfInvestments`	$3.59M	USD	Annual
Change in fair value of the Series A and B warrants and embedded derivatives	`DerivativeGainLossOnDerivativeNet`	$-40.41M	USD	Annual
Change in fair value of the Series A and B warrants and embedded derivatives	`DerivativeGainLossOnDerivativeNet`	$13.10M	USD	Annual
Loss on foreign currency exchange	`ForeignCurrencyTransactionGainLossBeforeTax`	$-89.00K	USD	Annual
Loss on foreign currency exchange	`ForeignCurrencyTransactionGainLossBeforeTax`	$-3.32M	USD	Annual
Interest expense on Senior Secured Notes	`InterestExpenseDebt`	$7.92M	USD	Annual
Interest expense on Senior Secured Notes	`InterestExpenseDebt`	$6.43M	USD	Annual
Interest income and other, net	`OtherNonoperatingIncomeExpense`	$501.00K	USD	Annual
Interest income and other, net	`OtherNonoperatingIncomeExpense`	$5.44M	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$160.11M	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$-87.06M	USD	Annual
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$174.65M	USD	Annual
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-127.15M	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-16.21M	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$24.29M	USD	Annual
Net (loss) income including noncontrolling interests in subsidiaries	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-110.94M	USD	Annual
Net (loss) income including noncontrolling interests in subsidiaries	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$150.37M	USD	Annual
Net income attributable to noncontrolling interests in subsidiaries	`NetIncomeLossAttributableToNoncontrollingInterest`	$14.13M	USD	Annual
Net income attributable to noncontrolling interests in subsidiaries	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.17M	USD	Annual
Net (loss) income attributable to Acacia Research Corporation	`NetIncomeLoss`	$-125.06M	USD	Annual
Net (loss) income attributable to Acacia Research Corporation	`NetIncomeLoss`	$149.20M	USD	Annual
Net (loss) income attributable to common stockholders - Basic	`NetIncomeLossAvailableToCommonStockholdersBasic`	$118.80M	USD	Annual
Net (loss) income attributable to common stockholders - Basic	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-133.03M	USD	Annual
Weighted average number of shares outstanding - Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	48.80M	shares	Annual
Weighted average number of shares outstanding - Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	42.46M	shares	Annual
Basic net income (loss) per common share (in usd per share)	`EarningsPerShareBasic`	$2.43	USD	Annual
Basic net income (loss) per common share (in usd per share)	`EarningsPerShareBasic`	$-3.13	USD	Annual
Net (loss) income attributable to common stockholders - Diluted	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-133.03M	USD	Annual
Net (loss) income attributable to common stockholders - Diluted	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$188.22M	USD	Annual
Weighted average number of shares outstanding - Diluted	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	98.47M	shares	Annual
Weighted average number of shares outstanding - Diluted	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	42.46M	shares	Annual
Diluted net income (loss) per common share (in usd per share)	`EarningsPerShareDiluted`	$1.91	USD	Annual
Diluted net income (loss) per common share (in usd per share)	`EarningsPerShareDiluted`	$-3.13	USD	Annual

Cash Flow Statement 99 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income including noncontrolling interests in subsidiaries	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-110.94M	USD	Annual
Net (loss) income including noncontrolling interests in subsidiaries	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$150.37M	USD	Annual
Change in fair value of investment	`IncreaseDecreaseInTradingSecurities`	$-2.75M	USD	Annual
Change in fair value of investment	`IncreaseDecreaseInTradingSecurities`	-	USD	Annual
Gain on sale of investment	`GainLossOnSaleOfInvestments`	-	USD	Annual
Gain on sale of investment	`GainLossOnSaleOfInvestments`	$3.59M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.51M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$10.69M	USD	Annual
Amortization of debt discount and issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$90.00K	USD	Annual
Amortization of debt discount and issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$110.00K	USD	Annual
Change in fair value of Series A redeemable convertible preferred stock embedded derivatives	`ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative`	$1.61M	USD	Annual
Change in fair value of Series A redeemable convertible preferred stock embedded derivatives	`ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative`	$8.28M	USD	Annual
Change in fair value of Series A warrants	`UnrealizedGainLossOnDerivatives`	$1.90M	USD	Annual
Change in fair value of Series A warrants	`UnrealizedGainLossOnDerivatives`	$-4.65M	USD	Annual
Change in fair value of Series B warrants	`UnrealizedGainLossOnDerivatives1`	$-44.04M	USD	Annual
Change in fair value of Series B warrants	`UnrealizedGainLossOnDerivatives1`	$11.60M	USD	Annual
Loss from Warrant Exercises	`LossFromWarrantExercises`	-	USD	Annual
Loss from Warrant Exercises	`LossFromWarrantExercises`	$-2.00M	USD	Annual
Compensation expense for share-based awards	`ShareBasedCompensation`	$3.82M	USD	Annual
Compensation expense for share-based awards	`ShareBasedCompensation`	$2.05M	USD	Annual
Loss on foreign currency exchange	`ForeignCurrencyTransactionGainLossRealized`	$-3.32M	USD	Annual
Loss on foreign currency exchange	`ForeignCurrencyTransactionGainLossRealized`	$-89.00K	USD	Annual
Change in fair value of equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-263.69M	USD	Annual
Change in fair value of equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$87.53M	USD	Annual
Gain on sale of equity securities	`DebtSecuritiesRealizedGainLoss`	$116.13M	USD	Annual
Gain on sale of equity securities	`DebtSecuritiesRealizedGainLoss`	$125.32M	USD	Annual
Earnings on equity investment in joint venture	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$42.53M	USD	Annual
Earnings on equity investment in joint venture	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$3.53M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$15.74M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-17.81M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$747.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-998.00K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$5.29M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-1.91M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$78.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.99M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$760.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-136.00K	USD	Annual
Royalties and contingent legal fees payable	`IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable`	$301.00K	USD	Annual
Royalties and contingent legal fees payable	`IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable`	$-1.76M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$100.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-246.00K	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.33M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-37.34M	USD	Annual
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$33.25M	USD	Annual
Patent acquisition	`PaymentsToAcquireIntangibleAssets`	$21.00M	USD	Annual
Patent acquisition	`PaymentsToAcquireIntangibleAssets`	$5.00M	USD	Annual
Sale of investment at fair value	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$3.59M	USD	Annual
Sale of investment at fair value	`ProceedsFromSaleAndMaturityOfOtherInvestments`	-	USD	Annual
Purchases of equity securities	`PaymentsToAcquireShortTermInvestments`	$66.62M	USD	Annual
Purchases of equity securities	`PaymentsToAcquireShortTermInvestments`	$112.14M	USD	Annual
Sales of equity securities	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$154.78M	USD	Annual
Sales of equity securities	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$273.93M	USD	Annual
Distributions received from equity investment in joint venture	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$2.36M	USD	Annual
Distributions received from equity investment in joint venture	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$28.40M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$732.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$91.00K	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$184.46M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$35.75M	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$4.01M	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$50.99M	USD	Annual
Issuance of Senior Secured Notes, net of lender fee	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Issuance of Senior Secured Notes, net of lender fee	`ProceedsFromIssuanceOfDebt`	$115.00M	USD	Annual
Paydown of Senior Secured Notes	`RepaymentsOfSecuredDebt`	$120.00M	USD	Annual
Paydown of Senior Secured Notes	`RepaymentsOfSecuredDebt`	$50.00M	USD	Annual
Dividend on Series A Redeemable Convertible Preferred Stock	`PaymentsOfDividends`	$2.80M	USD	Annual
Dividend on Series A Redeemable Convertible Preferred Stock	`PaymentsOfDividends`	$1.45M	USD	Annual
Taxes paid related to net share settlement of share-based awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.60M	USD	Annual
Taxes paid related to net share settlement of share-based awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	Annual
Proceeds from exercise of Series A warrants	`ProceedsFromWarrantExercises`	$9.30M	USD	Point-in-time
Proceeds from exercise of Series A warrants	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from exercise of Series A warrants	`ProceedsFromWarrantExercises`	$9.25M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$202.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-166.14M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$59.74M	USD	Annual
Effect of exchange rates on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.57M	USD	Annual
Effect of exchange rates on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Annual
(Decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$108.81M	USD	Annual
(Decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-21.57M	USD	Annual
Cash and cash equivalents and restricted cash, beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$309.36M	USD	Point-in-time
Cash and cash equivalents and restricted cash, beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$287.79M	USD	Point-in-time
Cash and cash equivalents and restricted cash, beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$200.55M	USD	Point-in-time
Cash and cash equivalents and restricted cash, ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$309.36M	USD	Point-in-time
Cash and cash equivalents and restricted cash, ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$287.79M	USD	Point-in-time
Cash and cash equivalents and restricted cash, ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$200.55M	USD	Point-in-time
Interest paid	`IncreaseDecreaseInPrepaidInterest`	$7.34M	USD	Annual
Interest paid	`IncreaseDecreaseInPrepaidInterest`	$7.23M	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$25.00K	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$384.00K	USD	Annual
Patent acquisition in exchange of notes receivable	`PatentAcquisitionInExchangeOfNotesReceivable`	-	USD	Annual
Patent acquisition in exchange of notes receivable	`PatentAcquisitionInExchangeOfNotesReceivable`	$4.00M	USD	Annual
Accrued patent costs	`PatentAcquisitionAccruedLiabilityLongTerm`	$5.00M	USD	Annual
Accrued patent costs	`PatentAcquisitionAccruedLiabilityLongTerm`	$9.00M	USD	Annual
Distribution to noncontrolling interests in subsidiaries	`DistributionToNoncontrollingInterestsInSubsidiaries`	$14.13M	USD	Annual
Distribution to noncontrolling interests in subsidiaries	`DistributionToNoncontrollingInterestsInSubsidiaries`	$1.17M	USD	Annual
Cash distributed for notes receivable	`PaymentsToAcquireNotesReceivable`	$4.02M	USD	Annual
Cash distributed for notes receivable	`PaymentsToAcquireNotesReceivable`	-	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$430.48M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$269.32M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$288.32M	USD	Point-in-time
Net income including noncontrolling interests in subsidiaries	`ProfitLoss`	$-110.94M	USD	Annual
Net income including noncontrolling interests in subsidiaries	`ProfitLoss`	$150.37M	USD	Annual
Distributions to noncontrolling interests in subsidiaries	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$1.17M	USD	Annual
Distributions to noncontrolling interests in subsidiaries	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$14.13M	USD	Annual
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	`AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock`	$5.17M	USD	Annual
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value	`AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock`	$3.83M	USD	Annual
Dividend on Series A Redeemable Convertible Preferred Stock	`DividendsPreferredStockStock`	$2.80M	USD	Annual
Dividend on Series A Redeemable Convertible Preferred Stock	`DividendsPreferredStockStock`	$1.45M	USD	Annual
Stock Issued During Period, Value, Warrants Exercised	`StockIssuedDuringPeriodValueWarrantsExercised`	$20.65M	USD	Annual
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$202.00K	USD	Annual
Shares withheld related to net share settlement of share-based awards	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.60M	USD	Annual
Compensation expense for share-based awards	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.82M	USD	Annual
Compensation expense for share-based awards	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.05M	USD	Annual
Repurchase of common stock	`StockRepurchasedAndRetiredDuringPeriodValue`	$50.99M	USD	Annual
Repurchase of common stock	`StockRepurchasedAndRetiredDuringPeriodValue`	$4.01M	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$430.48M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$269.32M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$288.32M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.